Resignation of Michael P. Haydock at Cray, Chairman James Rottsolk returns as President and CEO

Seattle 05 March 2002 Michael P. Haydock has resigned as president and chief executive officer at Cray Inc. and from the company's board of directors due to differences with the board of directors in how to restore the company to long-term industry leadership. Cray remains committed to the strategic plan developed last autumn, to current financial guidance for 2002 and, most importantly, to profitability. To achieve consistent profitability the company is committed to carefully controlling expenses and developing a cost structure that matches its revenue stream.

James E. Rottsolk, formerly president and chief executive officer of the company, has reassumed those positions. He stated that the company would continue searching for additional senior operating management.

According to Rottsolk, the overall goals are to create a financially strong and profitable company and to restore Cray to its premier position in the high performance computer industry. First, Cray will complete the development of the SV2 system, with initial deliveries scheduled for the second half of this year, and begin work on the code-named Cray SV2e follow-on series.

The company will ramp up sales of the Cray SX-6 series of supercomputers from NEC into the industrial, weather and other classic vector markets that require the powerful performance that these systems provide.

Cray will finish developing the MTA-2 series of multithreaded architecture supercomputers. It has achieved impressive scaling results on the MTA-2 during in-house testing, and has installed a 16-processor system at the Naval Research Laboratory. The current priority is to complete delivery of a 40-processor system to the Naval Research Laboratory in the second quarter.

The company will expand its technology and services relationship with the Dell Computer Corporation and continue its entry into professional services, leveraging its world-class reputation and skills for services and industry technical leadership. Cray will also continue to market and sell the Cray SV1ex system, particularly into the growing bioinformatics market.


Ad Emmen

[News on Advanced IT][Calendar][Analysis][IT in Medicine]